Dentsply Sirona (XRAY) Stock
Key stats
- Market cap
- $1.94B
- Price / Earnings ratio
- -3.6x
- EPS (TTM)
- -$2.74
- Volume
- Loading
- 52-week high
- $14.76
- 52-week low
- $8.32
- EPS vs analyst estimate
- -17.8%Q3 FY25 · $0.37 vs $0.45
- Next earnings report
- 5 Nov 2026
Source: third-party data provider, as of November 5, 2026
EPS estimate: analyst consensus
Compare with XRAY
Recent news

Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal
Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal
XRAY

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
XRAY
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 68.48
- MACD 12/26/9
- 0.16
- EMA 9 of MACD
- -0.05
- MACD histogram
- 0.20
- SMA 50
- $9.65
- Price above SMA 50
- EMA 50
- $9.75
- Price above EMA 50
- SMA 200
- $11.30
- Price below SMA 200
- EMA 200
- $10.88
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 4, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 6 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.39 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal
Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal
XRAY

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
XRAY

DENTSPLY SIRONA Q2 Earnings Call Highlights
DENTSPLY SIRONA Q2 Earnings Call Highlights
XRAY

XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales
XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales
XRAY

Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings
XRAY

Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates
XRAY

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
XRAY

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
XRAY
News tone: automated (AI) classification of the article's content, not a price prediction.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care. Our products and solutions include leading positions and platforms across consumables, equipment, technology, and specialty products.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel T. Scavilla | President, CEO, Interim Principal Financial Officer & Director | 1965 |
| Mr. John C. Fortson | Executive VP & CFO | 1967 |
| Ms. Andrea L. Frohning | Senior VP & Chief Human Resources Officer | 1970 |
| Mr. Robert Anthony Johnson | Senior VP & Chief Supply Chain Officer | 1969 |
| Mr. Aldo M. Denti | Executive VP & Chief Commercial Officer | 1968 |
| Mr. Kevin J. Czerney | Vice President & Chief Accounting Officer | 1984 |
| Mr. Kevin Boyle | Senior VP & Chief Technology Officer | — |
| Mr. John Stevens | Senior Vice President and Chief Information Officer | — |
| Wade Moody | Senior Manager of Investor Relations | — |
| Ms. Lindi Barton-Brobst | Senior VP & General Counsel | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 5, 2026
Technical indicators
- RSI 14
- 68.48
- MACD 12/26/9
- 0.16
- EMA 9 of MACD
- -0.05
- MACD histogram
- 0.20
- SMA 50
- $9.65
- Price above SMA 50
- EMA 50
- $9.75
- Price above EMA 50
- SMA 200
- $11.30
- Price below SMA 200
- EMA 200
- $10.88
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 4, 2026. Technical data, not a recommendation.
Analyst views
6 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $10.00
- Average
- $11.33
- High
- $13.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -12.9 | +15.5 | ||||||||||
| 2022 | -6.1 | +1.9 | -9.5 | -18.8 | -0.2 | -8.5 | -0.1 | -8.9 | -11.9 | +5.6 | -2.4 | +1.3 |
| 2023 | +12.7 | +1.6 | +5.1 | +7.2 | -14.8 | +6.3 | +4.8 | -10.3 | -8.9 | -10.0 | +3.0 | +9.3 |
| 2024 | -2.5 | -5.8 | -0.2 | -6.9 | -7.2 | -11.2 | +10.2 | -5.4 | +8.2 | -11.3 | -16.3 | -4.2 |
| 2025 | +5.4 | -14.5 | -6.6 | -5.1 | +14.7 | +1.7 | -13.5 | +0.0 | -8.1 | -2.6 | -9.6 | +2.2 |
| 2026 | +10.6 | +20.2 | -18.9 | +0.8 | -11.3 | +5.9 | +20.6 | -20.9 | -17.7 | +9.0 | -1.7 |
Corporate actions
Upcoming
No upcoming corporate actions for XRAY



